# Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites

> **NCT04771676** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 25 (actual)

## Conditions studied

- Refractory Malignant Ascites

## Interventions

- **DRUG:** Oncorine (H101)

## Key facts

- **NCT ID:** NCT04771676
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04771676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04771676, "Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04771676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*